Identification of an updated set of prescribing-safety indicators for GPs

Background

Medication error is an important contributor to patient morbidity and mortality and is associated with inadequate patient safety measures. However, prescribing-safety tools specifically designed for use in general practice are lacking.

Aim

To identify and update a set of prescribing-safety indicators for assessing the safety of prescribing in general practice, and to estimate the risk of harm to patients associated with each indicator.

Design and setting

RAND/UCLA consensus development of indicators in UK general practice.

Method

Prescribing indicators were identified from a systematic review and previous consensus exercise. The RAND Appropriateness Method was used to further identify and develop the indicators with an electronic-Delphi method used to rate the risk associated with them. Twelve GPs from all the countries of the UK participated in the RAND exercise, with 11 GPs rating risk using the electronic-Delphi approach.

Results

Fifty-six prescribing-safety indicators were considered appropriate for inclusion (overall panel median rating of 7–9, with agreement). These indicators cover hazardous prescribing across a range of therapeutic indications, hazardous drug–drug combinations and inadequate laboratory test monitoring. Twenty-three (41%) of these indicators were considered high risk or extreme risk by 80% or more of the participants.

Conclusion

This study identified a set of 56 indicators that were considered, by a panel of GPs, to be appropriate for assessing the safety of GP prescribing. Twenty-three of these indicators were considered to be associated with high or extreme risk to patients and should be the focus of efforts to improve patient safety.     

晚期产后出血诊治专家共识

        晚期产后出血（late postpartum hemorrhage）是产褥期常见并发症,发生率为0.5%~2%,临床医生对其重视程度和处理方案与普通产后出血相比相差甚远［1-2］。如未及时识别和正确处理,同样可能发生大出血、休克等严重并发症,甚至危及生命。目前国际上缺乏共识或指南,鉴于此,中华医学会围产医学分会在参考国外晚期产后出血诊治文献的基础上［2-3］,结合我国现状特制定本专家共识,由于缺乏高质量的证据,本文未对推荐意见进行分级,希望在尽快规范晚期产后出血临床处理的同时,推动良好设计的临床研究的开展。     

小阴唇整形术专家共识（2020年版）

        随着社会的发展,人们对美的追求越来越高,小阴唇整形也逐渐受到人们的关注。尽管小阴唇整形术方法有很多,但手术指征、手术方式选择、围术期管理及术后并发症防治等缺乏统一的标准［1-2］。中国整形美容协会女性生殖整复分会组织专家,根据文献报道［3］和专家经验,经过反复的讨论和修改,对小阴唇整形术提出如下共识,以期为临床医生对小阴唇肥大的诊治及整形决策提供参考及借鉴。 浏览更多请关注本刊微信公众号及当期杂志。     

自然流产诊治中国专家共识（2020年版）

自然流产（spontaneous abortion,SA）是妇产科最常见的妊娠并发症之一。育龄期女性发生1次SA的风险为10%左右［1］。复发性流产（recurrent spontaneous abortion,RSA）的发生率为1%～5%［2］,RSA的复发风险随着流产次数的增加而上升。曾有3次以上连续自然流产史的患者再次妊娠后胚胎丢失率为40%～80%［3］。如果不及时干预,不仅会给患者及其家庭带来严重的经济负担,而且还将对患者的身心健康造成极大的影响。 浏览更多请关注本刊微信公众号及当期杂志。     

Surgical treatment of hepatocellular carcinoma: expert consensus statement

As the number of effective treatment options has increased, the management of patients with hepatocellular carcinoma has become complex. The most appropriate therapy depends largely on the functional status of the underlying liver. In patients with advanced cirrhosis and tumor extent within the Milan criteria, liver transplantation is clearly the best option, as this therapy treats the cancer along with the underlying hepatic parenchymal disease. As the results of transplantation has become established in patients with limited disease, investigation has increasingly focused on downstaging patients with disease outside of Milan criteria and defining the upper limits of transplantable tumors. In patients with well preserved hepatic function, liver resection is the most appropriate and effective treatment. Hepatic resection is not as constrained by tumor extent and location to the same degree as transplantation and ablative therapies. Some patients who recur after resection may still be eligible for transplantation. Ablative therapies, particularly percutaneous radiofrequency ablation and transarterial chemoembolization have been used primarily to treat patients with low volume irresectable tumors. Whether ablation of small tumors provides long term disease control that is comparable to resection remains unclear.     

Antibody responses against B-cell epitopes of the hypervariable region 1 of hepatitis C virus in self-limiting and chronic human hepatitis C followed-up using consensus peptides.

A rare collection of serum samples from patients with hepatitis C virus (HCV) infection followed up from the onset of clinical symptoms was acquired. RNA corresponding to the hypervariable region 1 (HVR1) of E2 protein of HCV isolated from nine patients was reverse-transcribed, amplified, sequenced, and HVR1 amino acid sequences were deduced. These sequences and a selection of HVR1 amino acid sequences of matching HCV genotypes from protein and translated DNA sequence databanks were used to create the HVR1 amino acid consensus. The degenerated peptides mimicking N- and C-termini of the consensus were synthesized. Most (76%) of 17 patients followed up for the period from 1 week to a minimum of 7 months from the onset of acute symptoms developed antibodies reacting with peptides representing N- and/or C- termini of HVR1. Antibody recognition of the consensus HVR1 peptides indicates that the variability of HVR1 sequence on the protein level is limited with certain conserved structure(s) being untouched. A tendency was observed for a slower development of anti-HVR1 antibody response in patients developing chronic HCV, as compared to those with self-limiting HCV infection.     

预防剖宫产粘连的中国专家共识（2016）

        剖宫产粘连是指剖宫产手术后盆腹腔组织和器官之间的异常纤维连接,根据部位和涉及组织和器官不同,粘连可能会导致各种并发症如疼痛、不孕、肠梗阻等。为了预防和减少剖宫产粘连的发生,结合国内剖宫产现状制定本共识。     

创面修复科护士职业标准的全国专家共识

创面修复科是一门新兴学科,目前尚没有护士职业标准。为更好地规范和加强创面修复科护士队伍的能力和体系建设,中国老年医学学会烧创伤分会、中国医师协会中国创面修复科标准化建设专家委员会、全国创面修复专科联盟组织国内专家,从术语和定义、通用条件、职业要求、技能要求、培训要求、考试考核及颁证等方面,撰写了创面修复科护士职业标准的全国专家共识,供全国同行参考。     

Identification of a Strong Promoter of Bacteriophage MB78 that Lacks Consensus Sequence Around Minus 35 Region and Interacts with Phage Specific Factor

A strong promoter of bacteriophage MB78 does not have minus 35 consensus sequence although it has a TGn motif immediately upstream of minus 10 sequence as well as the AT rich UP element. It is efficiently recognised by the sigma 70 RNA polymerase, however, a phage-specific factor competes with sigma 70 RNA polymerase for binding to this region, the binding of the factor being stronger than that of the polymerase. Contrary to the reports in the literature the polymerase appears not to bind to the UP element whereas the phage-specific factor does. The latter seems to be involved in the regulation of the promoter activity. This revised version was published online in July 2006 with corrections to the Cover Date.